Cargando…

Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form

Objectives: Ertugliflozin is a selective sodium-glucose cotransporter 2 inhibitor approved for the treatment of type 2 diabetes in adults. In its natural form, ertugliflozin exists as an amorphous solid with physicochemical properties that prevent commercial manufacture. The commercial product was d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sahasrabudhe, Vaishali, Matschke, Kyle, Shi, Haihong, Hickman, Anne, Kong, Angela, Rodríguez Spong, Barbara, Nickerson, Beverly, Arora, Kapildev K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dustri-Verlag Dr. Karl Feistle 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238437/ https://www.ncbi.nlm.nih.gov/pubmed/35575420 http://dx.doi.org/10.5414/CP204212

Ejemplares similares

Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
por: Dawra, Vikas Kumar, et al.
Publicado: (2020)

Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
por: Fediuk, Daryl J., et al.
Publicado: (2019)

Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin
por: Sahasrabudhe, Vaishali, et al.
Publicado: (2018)

Bioequivalence of Ertugliflozin/Metformin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
por: Dawra, Vikas Kumar, et al.
Publicado: (2019)

Pharmacokinetic Properties of Single and Multiple Doses of Ertugliflozin, a Selective Inhibitor of SGLT2, in Healthy Chinese Subjects
por: Li, Yinhua, et al.
Publicado: (2019)

Novel Application of the Two‐Period Microtracer Approach to Determine Absolute Oral Bioavailability and Fraction Absorbed of Ertugliflozin
por: Raje, Sangeeta, et al.
Publicado: (2018)

Formulation and optimisation of raft-forming chewable tablets containing H(2) antagonist
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

Pharmaceutical dosage forms--tablets /
Publicado: (1989)

A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects
por: Dawra, Vikas Kumar, et al.
Publicado: (2019)

Assessment of the Drug Interaction Potential of Ertugliflozin With Sitagliptin, Metformin, Glimepiride, or Simvastatin in Healthy Subjects
por: Dawra, Vikas Kumar, et al.
Publicado: (2018)

Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement
por: Ponnammal, Poovizhi, et al.
Publicado: (2018)

Drugs in Tablet Form (Sci. Mem.)
Publicado: (1912)

Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Healthy Japanese and Western Subjects
por: Li, Yinhua, et al.
Publicado: (2021)

Population Pharmacokinetic Analyses of Ertugliflozin in Select Ethnic Populations
por: Fediuk, Daryl J., et al.
Publicado: (2021)

Comparative Bioequivalence of Tablet and Capsule Formulations of Ulotaront and the Effect of Food on the Pharmacokinetics of the Tablet Form in Humans
por: Chen, Yu-Luan, et al.
Publicado: (2023)

The Effect of Humidity on the Dissolution Kinetics and Tablet Properties of Immediate-Release Tablet Formulation Containing Lamotrigine
por: Lalić-Popović, Mladena, et al.
Publicado: (2022)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Assessment of the stability of co-amorphous olanzapine in tablets
por: da Costa, Nuno F., et al.
Publicado: (2021)

RP-HPLC Estimation of Risperidone in Tablet Dosage Forms
por: Baldania, S. L., et al.
Publicado: (2008)

Spectrophotometric Determination of Diazepam in Pure form, Tablets and Ampoules
por: El-Hawary, W. F., et al.
Publicado: (2007)

The application of qNMR for the determination of rosuvastatin in tablet form
por: DİKMEN, Gökhan, et al.
Publicado: (2021)

Formulation and evaluation of sublingual tablets containing Sumatriptan succinate
por: Prajapati, Shailesh T, et al.
Publicado: (2012)

Investigation for the quality factors on the tablets containing medicated pellets
por: Tan, Xueying, et al.
Publicado: (2016)

A Precise Prediction Method for the Properties of API-Containing Tablets Based on Data from Placebo Tablets
por: Hayashi, Yoshihiro, et al.
Publicado: (2020)

Comparison of bioavailability between the most available generic tablet formulation containing artemether and lumefantrine on the Tanzanian market and the innovator’s product
por: Minzi, Omary MS, et al.
Publicado: (2013)

Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
por: Fediuk, Daryl J., et al.
Publicado: (2020)

Design, development, and characterization of amorphous rosuvastatin calcium tablets
por: González, Rocío, et al.
Publicado: (2022)

RP-HPLC Estimation of Venlafaxine Hydrochloride in Tablet Dosage Forms
por: Baldania, S. L., et al.
Publicado: (2008)

Simultaneous Spectrophotometric Estimation of Norfloxacin and Ornidazole in Tablet Dosage Form
por: Wankhede, S. B., et al.
Publicado: (2009)

RP-HPLC Method for the Estimation of Dutasteride in Tablet Dosage Form
por: Patel, Dipti B., et al.
Publicado: (2010)

Standard manufacturing procedure for syrup and tablet forms of Jwarahara Dashemani
por: Kalsariya, Bharat D., et al.
Publicado: (2010)

Colorimetric Method for the Estimation of Escitalopram Oxalate in Tablet Dosage Form
por: Vetrichelvan, T., et al.
Publicado: (2010)

Relative bioavailability of a pediatric dispersible tablet and adult film‐coated tablet of macitentan in healthy volunteers
por: Sidharta, Patricia N., et al.
Publicado: (2020)

In vivo bioavailability studies of sumatriptan succinate buccal tablets
por: Shivanand, K, et al.
Publicado: (2011)

Dehydroepiandrosterone Cocrystals with Improved Solubility and Bioavailability
por: Jiang, Yihua, et al.
Publicado: (2022)

The Cocrystal of Ubiquinol: Improved Stability and Bioavailability
por: Zhang, Qi, et al.
Publicado: (2023)

Stability-Indicating HPLC Method for the Simultaneous Determination of HIV Tablet Containing Emtricitabine, Tenofovir Disoproxil Fumarate, and Rilpivirine Hydrochloride in Pharmaceutical Dosage Forms
por: Venkatesan, S., et al.
Publicado: (2014)

Bioavailability Evaluation of Venetoclax Lower-Strength Tablets and Oral Powder Formulations to Establish Interchangeability with the 100 mg Tablet
por: Badawi, Mohamed, et al.
Publicado: (2022)

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
por: Sahasrabudhe, V., et al.
Publicado: (2017)

Combinations of Tautomeric Forms and Neutral-Cationic Forms in the Cocrystals of Sulfamethazine with Carboxylic Acids
por: Singh, Munendra Pal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v15jnsbumsgdhme8ss0btotilq